- Home
- CBRL vs MYGN Comparison
CBRL vs MYGN Comparison
Compare CBRL & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBRL
- MYGN
- Stock Information
- Founded
- CBRL 1969
- MYGN 1991
- Country
- CBRL United States
- MYGN United States
- Employees
- CBRL N/A
- MYGN N/A
- Industry
- CBRL Restaurants
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CBRL Consumer Discretionary
- MYGN Health Care
- Exchange
- CBRL Nasdaq
- MYGN Nasdaq
- Market Cap
- CBRL 826.1M
- MYGN 744.7M
- IPO Year
- CBRL N/A
- MYGN 1995
- Fundamental
- Price
- CBRL $43.34
- MYGN $7.42
- Analyst Decision
- CBRL Hold
- MYGN Hold
- Analyst Count
- CBRL 9
- MYGN 16
- Target Price
- CBRL $52.43
- MYGN $20.17
- AVG Volume (30 Days)
- CBRL 1.1M
- MYGN 1.3M
- Earning Date
- CBRL 05-29-2025
- MYGN 05-06-2025
- Dividend Yield
- CBRL 2.32%
- MYGN N/A
- EPS Growth
- CBRL N/A
- MYGN N/A
- EPS
- CBRL 1.60
- MYGN N/A
- Revenue
- CBRL $3,506,050,000.00
- MYGN $837,600,000.00
- Revenue This Year
- CBRL $1.94
- MYGN $2.96
- Revenue Next Year
- CBRL $1.81
- MYGN $8.36
- P/E Ratio
- CBRL $26.74
- MYGN N/A
- Revenue Growth
- CBRL 2.26
- MYGN 11.21
- 52 Week Low
- CBRL $33.85
- MYGN $7.16
- 52 Week High
- CBRL $65.43
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- CBRL 53.64
- MYGN 29.29
- Support Level
- CBRL $41.91
- MYGN $7.69
- Resistance Level
- CBRL $46.63
- MYGN $7.89
- Average True Range (ATR)
- CBRL 2.65
- MYGN 0.51
- MACD
- CBRL 0.62
- MYGN 0.04
- Stochastic Oscillator
- CBRL 72.49
- MYGN 17.69
About CBRL Cracker Barrel Old Country Store Inc
Cracker Barrel Old Country Store Inc operates hundreds of full-service restaurants throughout the United States. Its restaurants are open for breakfast, lunch, and dinner, with menus that offer home-style country food. Cracker Barrel's biggest input costs are beef, dairy, fruits and vegetables, pork, and poultry. The company purchases its food products from a few different vendors on a cost-plus basis. All restaurants are located in freestanding buildings and include gift shops, which contribute roughly one fourth of total company revenue. Apparel and accessories are the company's biggest revenue generators in the retail segment of the business.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.